Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

$2 Billion Immunofluorescence Assay: Global Market Report (2018-2023) - High Growth Opportunities in Emerging Markets -

Research and Markets
Posted on: 09 Mar 18

The "Immunofluorescence Assay Market by Product (Reagent, Primary & Secondary Antibody, Imaging Equipment, Immunofluorescence Microscopy), Type (Direct, Indirect), Disease (Cancer, Cardiovascular, Infectious Disease) & End User - Global Forecast to 2023" report has been added to's offering.

The global immunofluorescence assay market is projected to reach US$2.01 billion by 2023, from US$1.51 billion in 2018, at a CAGR of 5.8%.

The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare spending are the major factors driving the growth of the immunofluorescence assay market.

Based on type, the global immunofluorescence assay market is segmented into indirect and direct immunofluorescence. In 2017, the indirect immunofluorescence accounted for the largest share of the market. The advantages of this technique, such as its sensitivity, flexibility, better amplification of signal, and lower cost over direct immunofluorescence, is the key factor increasing the adoption of this technique.

On the basis of disease, the infectious diseases segment accounted for the largest share of the global immunofluorescence assay market in 2017. The large share of this segment is attributed to the increasing prevalence of infectious diseases across the globe, and the widespread adoption of immunofluorescence techniques, for the study and diagnosis of infectious diseases.

The prominent players in the global immunofluorescence assay market are Thermo Fisher (US), Inova Diagnostics (US), Bio-Rad (US), Abcam (UK), PerkinELmer (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), Danaher (US), and Vector Laboratories (US).

Key Market Dynamics


  • Increasing Prevalence of Chronic Diseases
  • Increasing R&D Spending
  • Increasing Healthcare Spending


  • High Cost of Instruments
  • Implementation of Excise Duty by the US Government


  • High Growth Opportunities in Emerging Markets


  • Quality Concerns Over Research Antibodies

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Immunofluorescence Assay Market, by Product

7 Immunofluorescence Assay Market, by Type

8 Immunofluorescence Assay Market, by Disease

9 Immunofluorescence Assay Market, by End User

10 Immunofluorescence Assay Market, by Region

11 Competitive Landscape

12 Company Profiles

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Inova Diagnostics (A Part of Werfern Company)
  • Medipan GmbH
  • Merck Millipore
  • Perkinelmer Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.
  • Vector Laboratories (A Part of Maravai Lifesciences)

For more information about this report visit

View source version on

Business Wire

Last updated on: 09/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.